At the conclusion of this activity, participants should be better prepared to:
Frankie Ann Holmes, MD, FACP
Associate Director, Breast Oncology Research
Physicians' Education Resource®, LLC, (PER®) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Puma Biotechnology, Inc.
The following individuals have no relevant financial relationships with commercial interests to disclose: Frankie Ann Holmes, MD, FACP
The staff of PER®: Ann C. Lichti, CHCP; Susan Peck, PhD; Michael Perlmutter, PharmD, MS
The following individuals have relevant financial relationships with commercial interests to disclose:
Mohammad Jahanzeb, MD, FACP - Research Support: Lilly, AbbVie, Genentech, Novartis; Consultant: Novartis; Joyce O'Shaughnessy, MD - Consultant: Arno Therapeutics, AstraZeneca, Celgene, Corcept, Eisai, Genentech, GlaxoSmithKline, Lilly, J&J, Merrimack Pharmaceuticals, Novartis, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, MedFusion
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.
PER®complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.
Jan 30, 2018
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid Malignancies
Jan 30, 2018
Cancer Summaries and Commentaries™: Update from San Diego - Advances in the Treatment of Multiple Myeloma
Jan 31, 2018
Jan 31, 2018